By Wallace Witkowski, MarketWatch

SAN FRANCISCO (MarketWatch) -- Can M&A save this stock market?

Over the past month, tech and small-cap stocks have been slammed as investors swapped last year's high-fliers for laggards like energy and value stocks. Worries have increased that corrections in stars like Tesla Motors Inc. (TSLA) , Facebook Inc. (FB) and biotech will spill to the rest of the market. The Nasdaq Composite (RIXF) suffered its worse weekly loss in a month.

Hang on, say some strategists. Rather than a wholesale rout, they expect the retreat in growth stocks to only cap the advance in the mega-cap benchmarks.

"It certainly will be a drag," said Paul Nolte, portfolio manager at Kingsview Asset Management. "The S&P 500 won't go significantly higher but you'll see significant dramatic sideways action."

Plus, record cash on corporate books may see its way to increased mergers and acquisition activity and investment -- and that may replace growth as the next catalyst.

"The next step to that is merger activity," Nolte said. " It's a way to grow business and earnings, where one plus one is greater than two."

Nolte said the weakness in techs and small-caps is a result of their outperformance in 2013, a view backed up by Bill Stone, chief investment strategist at PNC Asset Management Group.

"You're getting a correction in techs and small caps because those spots were the frothiest," Stone said.

The changing of the guard was at play last week. The one major index seeing a gain for the week was the Dow Jones Industrial Average(DJI), which finished up 0.4% to notch out a new record closing high of 16,583.34. The S&P 500 Index (SPX) finished the week down 0.1%.

On the other hand, the Nasdaq Composite Index (RIXF) finished down 1.3% on the week, with the small-cap Russell 2000 (RUT) falling 1.9% on the week. Several Russell components lost more than 25% on the week. Similarly, the iShares Russell 2000 ETF (IWM) fell 1.8% this past week, with nearly a 9% reduction in assets.

Facebook, a growth stock leader, ended Friday 21% from its 52-week high, or solidly in bear territory. Tesla is off 31% from its recent high. The iShares Nasdaq Biotech ETF (IBB) is off 18% from its peak.

(Read more on whether small-caps slide signals the market is in trouble http://www.marketwatch.com/story/small-caps-slide-reflects-a-market-in-trouble-2014-05-09.)

Stock pullbacks could prompt M&A

At the same time, U.S. companies are still sitting with record cash on the books and are under the gun to boost earnings growth after a muted first quarter. That could serve as a catalyst to more M&A after years of earnings growth built on cost cutting. Kingsview's Nolte said companies have already run though cycles of buybacks and dividends to boost stock prices and returns but now investors are looking for growth.

Buybacks are also falling out of fashion with higher stock prices, according to Savita Subramanian, equity and quant strategist at Bank of America Merrill Lynch. In a recent note, Subramanian points out that "companies have not historically timed buybacks well, and current valuations suggest the easy money has been made."

Subramanian notes that over the past few years share prices of large-cap companies on the Russell 1000 (RUI) have risen an average 0.5% a day after announcing an acquisition, compared to the long-term average of losing 0.1%. Much of this has to do with current cash hoards and lower interest rates as well as an over-reliance on buybacks and dividends lately.

Tech is one area where PNC's Stone sees a potential break-out in M&A activity, especially as it's the sector with a large portion of hoarded cash. Health-care is another sector that could see a rise in already active M&A activity, he said.

Stone notes that M&A deals over $1 billion rose in the first quarter, with 54 deals compared with the year-ago period, when there were 37. The value of the top 25 deals is even higher: $197.2 billion compared with $117.9 billion in the year-ago quarter. Those deals, however, are being financed more with stock. Some 42% were all-cash deals, compared with 69% as all-cash deals in the first quarter of 2013, according to Stone.

Outside of Comcast Corp.'s (CMCSA) $45 billion agreement to buy Time Warner Cable Inc. (TWC), some of the biggest deals this year have been in tech and health care.

There's Facebook Inc.'s (FB) $16 billion acquisition of WhatsApp Inc., Apple Inc.'s (AAPL) reported $3.2 billion deal to buy Beats Entertainment Inc., along with big-ticket pharma courtships like Pfizer Inc.'s (PFE) $106 billion bid for AstraZeneca PLC (AZN) and a campaign to buy Allergan Inc. (AGN) for $46 billion from Valeant Pharmaceuticals International Inc. (VRX) and Pershing Square Capital Management.

Many of those deals have been met with skepticism, but then again, with a low interest rate environment and growth still an issue, companies are more willing to take on riskier deals, Nolte said.

Retail earnings in focus

With more than 90% of the S&P 500 having already reported first-quarter earnings, attention in the next week shifts to retailers, which generally close out the season. It's already a given that bad winter weather will dent those first-quarter results, so much of the attention will go to outlooks.

Of the Dow components, Cisco Systems Inc. (CSCO) reports on Wednesday, and Wal-Mart Stores Inc. (WMT) reports on Thursday.

Outside of S&P 500 earnings reports from names like McKesson Corp.(MCK) , the week will mostly one of retail earnings reports from companies like Macy's Inc.(M) , Nordstrom Inc.(JWN) , Kohl's Corp.(KSS) , J.C. Penney Co.(JCP) , and Fossil Group Inc. (FOSL)

Of the 13 retail subsectors, only four (Internet retail, home improvement, automotive retail, and drug retail) are expected to report earnings growth for the first quarter. Analysts forecast 1.7% growth across all of retail, according to John Butters, senior earnings analyst at FactSet. Second-quarter earnings growth for retail is expected to rise by 5.8% in the second quarter, but that's down from the 9.8% growth expected back in late January.

"The market will likely pay close attention to any guidance issued by retailers for Q2 to see what factors other than weather may or may not be driving these downward estimate revisions," said Butters.

More from MarketWatch:

Stocks rise; Dow sets record, Nasdaq sees weekly fall

Coffee merger to be financed with $10 billion of debt

5 awful Mother's Day gifts

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

J C Penney (NYSE:JCP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more J C Penney Charts.
J C Penney (NYSE:JCP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more J C Penney Charts.